Clinical Education Initiative
HIV, HCV & STD Clinical Education Initiative
New York State Department of Health • AIDS Institute
Online CE Login
Request Onsite Training
Home > Learning Modules > Adherence to Antiretroviral Therapy Among Substance Users
Adherence to Antiretroviral Therapy Among Substance Users
Adherence to Antiretroviral Therapy Among Substance Users
Adherence to Antiretroviral Therapy Among Substance Users
Play
Sorry, this learning module is not available for mobile devices.

Resource ID: CM914

  • Tanya Zangaglia, M.D.
    Medical Director
    Project Streetbeat
Original Presentation: 6/8/2012
Web Posting: 6/8/2012
CE Expiration: 02/27/2016
To help clinicians understand the unique issues of adherence to antiretroviral therapy for all substance using clients who are HIV positive.
Learning Objectives
  1. State that near perfect adherence (>90-95%) is the goal for HIV – infected patients.
  2. Identify at least three factors related to adherence.
  3. Identify three potential barriers to adherence.
  4. State the importance of discussion of adherence & the development of antiretroviral resistance with clients.
Presenter Bio
Tanya Zangaglia, M.D.
Dr. Zangaglia is the Medical Director for Project Streetbeat as well as a Lecturer for the AIDS Education & Training Centers and Clinical Education Initiative (CEI).
Content